HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Long-Term Therapy With Indirect Anticoagulants in Patients With Nonvalvular Atrial Fibrillation (Prospective Follow-Up Study). Part II. Effectiveness and Safety].

AbstractAIM:
To assess efficacy and safety of long-term international normalized ratio (INR) guided therapy with acenocoumarol in patients with nonvalvular atrial fibrillation.
MATERIAL:
Patients (n=100) with nonvalvular atrial fibrillation and at least 1 risk factor of thromboembolic complications.
METHODS:
Ischemic strokes, episodes of systemic thromboembolism and hemorrhagic complications were registered during 3 years of treatment with acenocoumarol (target INR 2.0-3.0).
RESULTS:
Annual rates of ischemic strokes, hemorrhagic complications and major bleeding were 0.7, 14.4 and 1.1%, respectively. No episodes of thromboembolism were registered in patients with history of thromboembolic complications. Basing on data collected predictors of bleeding complications in patients with atrial fibrillation during long term treatment with acenocoumarol were elucidated.
AuthorsE S Kropacheva, E P Panchenko, A B Dobrovol'skiĭ, D M Ataullakhanova, E S Bykova, E V Titaeva, O Iu At'kov
JournalKardiologiia (Kardiologiia) Vol. 44 Issue 7 Pg. 10-6 ( 2004) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleDlitel'naia terapiia nepriamymi antikoaguliantami bol'nykh s mertsatel'noĭ aritmieĭ bez porazheniia klapanov serdtsa (prospektivnoe nabliudenie). Chast' II. Effektivnost' i bezopasnost' 3-letneĭ terapii.
PMID15340340 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Warfarin
Topics
  • Anticoagulants (therapeutic use)
  • Atrial Fibrillation
  • Follow-Up Studies
  • Humans
  • Prospective Studies
  • Warfarin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: